Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity

Tuberculosis

Volumn 93, Issue SUPPL., 2013, Pages

  Stew, Samuel S ^a,b   Martinez, Perla J ^a   Schlesinger, Larry S ^c   Restrepo, Blanca I ^c  

^a School of Public Health at Brownsville   (United States)

^b Advisory Board Company   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

CCR2; CD11b; Diabetes; Innate immunity; Monocyte; RAGE; Tuberculosis

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD36 ANTIGEN; CHEMOKINE RECEPTOR CCR2; HLA DR ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; TUBERCULOSIS;

CCR2; CD11B; DIABETES; INNATE IMMUNITY; MONOCYTE; RAGE; TUBERCULOSIS;

AGING; ANTIGENS, CD11B; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BODY MASS INDEX; CELL ADHESION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; RECEPTORS, CCR2; RECEPTORS, CELL SURFACE; TUBERCULOSIS;

EID: 84891613972     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/S1472-9792(13)70015-5     Document Type: Article

References (34)

1. CY Jeon, MB Murray Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies PLoS Med 5 2008 1091 1101
2. BI Restrepo Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances Clin Infect Dis 45 2007 436 438
3. B Restrepo, S Fisher-Hoch, B Smith, S Jeon, MH Rahbar, J McCormick Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes Am J Trop Med Hyg 79 2008 541 544
4. MA Baker, AD Harries, CY Jeon, JE Hart, A Kapur, K Lonnroth et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review BMC Med 9 2011 81
5. JE Stalenhoef, B Alisjahbana, EJ Nelwan, V van d, TH Ottenhoff, JW van der Meer et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus Eur J Clin Microbiol Infect Dis 27 2008 97 103
6. M Walsh, A Camerlin, R Miles, P Pino, P Martinez, F Mora-Guzman et al. Sensitivity of Interferon-gamma release assays is not compromised in tuberculosis patients with diabetes Int J Tuberc Lung Dis 15 2010 179 184
7. B Restrepo, S Fisher-Hoch, P Pino, A Salinas, MH Rahbar, F Mora et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells Clin Infect Dis 47 2008 634 641
8. NP Kumar, R Sridhar, VV Banurekha, MS Jawahar, TB Nutman, S Babu Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus J Infect Dis 208 2013 739 748
9. K Tsukaguchi, H Okamura, M Ikuno, A Kobayashi, A Fukuoka, H Takenaka et al. [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis] Kekkaku 72 1997 617 622
10. LS Schlesinger, CG Bellinger-Kawahara, NR Payne, MA Horwitz Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 J Immunol 144 1990 2771 2780
11. S Gordon, PR Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964
12. NV Serbina, T Jia, TM Hohl, EG Pamer Monocyte-mediated defense against microbial pathogens Annu Rev Immunol 26 2008 421 452
13. HW Ziegler-Heitbrock, G Fingerle, M Strobel, W Schraut, F Stelter, C Schutt et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages Eur J Immunol 23 1993 2053 2058
14. G Fingerle, A Pforte, B Passlick, M Blumenstein, M Strobel, HW Ziegler-Heitbrock The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients Blood 82 1993 3170 3176
15. NV Serbina, M Cherny, C Shi, SA Bleau, NH Collins, JW Young et al. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia J Immunol 183 2009 2678 2687
16. P Chimma, C Roussilhon, P Sratongno, R Ruangveerayuth, K Pattanapanyasat, JL Perignon et al. A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria PLoS Pathog 5 2009 e1000631
17. L Balboa, MM Romero, JI Basile, CA Garcia, P Schierloh, N Yokobori et al. Paradoxical role of CD16+CCR2+CCR5+ monocytes in tuberculosis: efficient APC in pleural effusion but also mark disease severity in blood J Leukoc Biol 90 2011 69 75
18. GP Fadini, SV de Kreutzenberg, E Boscaro, M Albiero, R Cappellari, N Krankel et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy Diabetologia 56 2013 1856 1866
19. DI Gomez, M Twahirwa, LS Schlesinger, BI Restrepo Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control Tuberculosis (Edinb) 93 2013 192 197
20. B Restrepo, A Camerlin, M Rahbar, M Restrepo, I Zarate, R Wing et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis patients Bull World Health Organ 89 2011 352 359
21. BJ Rutledge, H Rayburn, R Rosenberg, RJ North, RP Gladue, CL Corless et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens J Immunol 155 1995 4838 4843
22. LS Schlesinger Entry of Mycobacterium tuberculosis into mononuclear phagocytes Curr Top Microbiol Immunol 215 1996 71 96
23. V Quesniaux, C Fremond, M Jacobs, S Parida, D Nicolle, V Yeremeev et al. Toll-like receptor pathways in the immune responses to mycobacteria Microbes Infect 6 2004 946 959
24. M Hawkes, X Li, M Crockett, A Diassiti, C Finney, G Min-Oo et al. CD36 deficiency attenuates experimental mycobacterial infection BMC Infect Dis 10 2010 299
25. A Arce-Mendoza, IJ Rodriguez-de, MC Salinas-Carmona, AG Rosas-Taraco Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis Arch Med Res 39 2008 306 311
26. MA van Zoelen, CW Wieland, GJ van der Windt, S Florquin, PP Nawroth, A Bierhaus et al. Receptor for advanced glycation end products is protective during murine tuberculosis Mol Immunol 52 2012 183 189
27. Y Sun, M Scavini, RA Orlando, GH Murata, KS Servilla, AH Tzamaloukas et al. Increased CD36 expression signals monocyte activation among patients with type 2 diabetes Diabetes Care 33 2010 2065 2067
28. J Panee Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes Cytokine 60 2012 1 12
29. T Vallerskog, GW Martens, H Kornfeld Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis J Immunol 184 2010 6275 6282
30. JA Philips, EJ Rubin, N Perrimon Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection Science 309 2005 1251 1253
31. XD Su, SS Li, YQ Tian, ZY Zhang, GZ Zhang, LX Wang Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes Arch Med Res 42 2011 596 601
32. LS Schlesinger Mycobacterium tuberculosis and the complement system Trends Microbiol 6 1998 47 49
33. B Vesosky, J Turner The influence of age on immunity to infection with Mycobacterium tuberculosis Immunol Rev 205 2005 229 243
34. CC Leung, TH Lam, WM Chan, WW Yew, KS Ho, G Leung et al. Lower risk of tuberculosis in obesity Arch Intern Med 167 2007 1297 1304